Logo image of BRY.CA

BRI-CHEM CORP (BRY.CA) Stock Fundamental Analysis

TSX:BRY - Toronto Stock Exchange - CA10778T1057 - Common Stock - Currency: CAD

0.355  +0.01 (+1.43%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BRY. BRY was compared to 13 industry peers in the Trading Companies & Distributors industry. BRY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BRY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BRY had negative earnings in the past year.
In the past year BRY had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BRY reported negative net income in multiple years.
In multiple years BRY reported negative operating cash flow during the last 5 years.
BRY.CA Yearly Net Income VS EBIT VS OCF VS FCFBRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.14%, BRY is doing worse than 92.31% of the companies in the same industry.
The Return On Equity of BRY (-8.45%) is worse than 84.62% of its industry peers.
BRY has a worse Return On Invested Capital (2.61%) than 84.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRY is in line with the industry average of 8.14%.
The 3 year average ROIC (6.80%) for BRY is well above the current ROIC(2.61%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.14%
ROE -8.45%
ROIC 2.61%
ROA(3y)5.09%
ROA(5y)-2.46%
ROE(3y)17.85%
ROE(5y)-3.54%
ROIC(3y)6.8%
ROIC(5y)N/A
BRY.CA Yearly ROA, ROE, ROICBRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

With a Operating Margin value of 1.95%, BRY is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
The Gross Margin of BRY (17.89%) is worse than 69.23% of its industry peers.
In the last couple of years the Gross Margin of BRY has grown nicely.
Industry RankSector Rank
OM 1.95%
PM (TTM) N/A
GM 17.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.03%
GM growth 5Y5.38%
BRY.CA Yearly Profit, Operating, Gross MarginsBRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRY is destroying value.
Compared to 1 year ago, BRY has about the same amount of shares outstanding.
The number of shares outstanding for BRY has been increased compared to 5 years ago.
BRY has a better debt/assets ratio than last year.
BRY.CA Yearly Shares OutstandingBRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
BRY.CA Yearly Total Debt VS Total AssetsBRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that BRY is in the distress zone and has some risk of bankruptcy.
BRY has a Altman-Z score of 1.74. This is amonst the worse of the industry: BRY underperforms 84.62% of its industry peers.
BRY has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
BRY has a better Debt to FCF ratio (1.25) than 92.31% of its industry peers.
BRY has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
BRY's Debt to Equity ratio of 1.03 is on the low side compared to the rest of the industry. BRY is outperformed by 76.92% of its industry peers.
Even though the debt/equity ratio score it not favorable for BRY, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 1.25
Altman-Z 1.74
ROIC/WACC0.3
WACC8.65%
BRY.CA Yearly LT Debt VS Equity VS FCFBRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

BRY has a Current Ratio of 1.48. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.
BRY has a worse Current ratio (1.48) than 76.92% of its industry peers.
BRY has a Quick Ratio of 1.48. This is a bad value and indicates that BRY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BRY (0.65) is worse than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.65
BRY.CA Yearly Current Assets VS Current LiabilitesBRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

0

3. Growth

3.1 Past

The earnings per share for BRY have decreased strongly by -440.00% in the last year.
BRY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.65%.
BRY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.67% yearly.
EPS 1Y (TTM)-440%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.7%
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y32.87%
Revenue growth 5Y-2.67%
Sales Q2Q%-18.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRY.CA Yearly Revenue VS EstimatesBRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
BRY.CA Yearly EPS VS EstimatesBRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.1 0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

BRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRY.CA Price Earnings VS Forward Price EarningsBRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

BRY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BRY is cheaper than 76.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BRY is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.52
EV/EBITDA 5.61
BRY.CA Per share dataBRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRY!.
Industry RankSector Rank
Dividend Yield N/A

BRI-CHEM CORP

TSX:BRY (2/13/2025, 7:00:00 PM)

0.355

+0.01 (+1.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-11 2024-11-11
Earnings (Next)03-26 2025-03-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.8%
Ins Owner ChangeN/A
Market Cap9.38M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 0.52
P/OCF 0.5
P/B 0.44
P/tB 0.44
EV/EBITDA 5.61
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY193.07%
OCF(TTM)0.71
OCFY199.66%
SpS3.38
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.14%
ROE -8.45%
ROCE 6.18%
ROIC 2.61%
ROICexc 2.61%
ROICexgc 2.61%
OM 1.95%
PM (TTM) N/A
GM 17.89%
FCFM 20.3%
ROA(3y)5.09%
ROA(5y)-2.46%
ROE(3y)17.85%
ROE(5y)-3.54%
ROIC(3y)6.8%
ROIC(5y)N/A
ROICexc(3y)6.8%
ROICexc(5y)N/A
ROICexgc(3y)6.8%
ROICexgc(5y)N/A
ROCE(3y)21.53%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.03%
GM growth 5Y5.38%
F-Score4
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 1.25
Debt/EBITDA 7.21
Cap/Depr 47.77%
Cap/Sales 0.69%
Interest Coverage 0.98
Cash Conversion 616.96%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.65
Altman-Z 1.74
F-Score4
WACC8.65%
ROIC/WACC0.3
Cap/Depr(3y)83.75%
Cap/Depr(5y)55.25%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-440%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y32.87%
Revenue growth 5Y-2.67%
Sales Q2Q%-18.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y274.69%
FCF growth 3Y5.5%
FCF growth 5Y84.59%
OCF growth 1Y284.38%
OCF growth 3Y7.48%
OCF growth 5Y44.85%